BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 23706418)

  • 21. Survivin expression impacts prognostically on NSCLC but not SCLC.
    Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A
    Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung.
    Ryuge S; Sato Y; Jiang SX; Wang G; Matsumoto T; Katono K; Inoue H; Iyoda A; Satoh Y; Yoshimura H; Masuda N
    Lung Cancer; 2012 Aug; 77(2):415-20. PubMed ID: 22572237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of RON in small and non-small cell lung cancers.
    Kanteti R; Krishnaswamy S; Catenacci D; Tan YH; EL-Hashani E; Cervantes G; Husain AN; Tretiakova M; Vokes EE; Huet H; Salgia R
    Genes Chromosomes Cancer; 2012 Sep; 51(9):841-51. PubMed ID: 22585712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.
    Yamahatsu K; Matsuda Y; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2012 May; 40(5):1345-57. PubMed ID: 22246533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells.
    Zhao H; Zhu L; Jin Y; Ji H; Yan X; Zhu X
    Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):177-82. PubMed ID: 22172490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
    Horie M; Miyashita N; Mattsson JSM; Mikami Y; Sandelin M; Brunnström H; Micke P; Nagase T; Saito A
    J Pathol; 2018 Oct; 246(2):154-165. PubMed ID: 29876935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokeratins negatively regulate the invasive potential of lung cancer cell lines.
    Kanaji N; Bandoh S; Ishii T; Fujita J; Ishida T; Matsunaga T; Kubo A
    Oncol Rep; 2011 Oct; 26(4):763-8. PubMed ID: 21701782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the prognostic impact of nestin expression in non-small cell lung cancer.
    Skarda J; Kolar Z; Janikova M; Radova L; Kolek V; Fridman E; Kopolovic J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun; 156(2):135-42. PubMed ID: 22837134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences of molecular expression mechanisms among neural cell adhesion molecule 1, synaptophysin, and chromogranin A in lung cancer cells.
    Kashiwagi K; Ishii J; Sakaeda M; Arimasu Y; Shimoyamada H; Sato H; Miyata C; Kamma H; Aoki I; Yazawa T
    Pathol Int; 2012 Apr; 62(4):232-45. PubMed ID: 22449227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation.
    Alam SK; Wang L; Ren Y; Hernandez CE; Kosari F; Roden AC; Yang R; Hoeppner LH
    Br J Cancer; 2020 Sep; 123(5):819-832. PubMed ID: 32499571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer.
    Yazawa T; Sato H; Shimoyamada H; Okudela K; Woo T; Tajiri M; Ogura T; Ogawa N; Suzuki T; Mitsui H; Ishii J; Miyata C; Sakaeda M; Goto K; Kashiwagi K; Masuda M; Takahashi T; Kitamura H
    Am J Pathol; 2009 Sep; 175(3):976-87. PubMed ID: 19679880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the stem cell-associated intermediate filament nestin in malignant proliferation of non-small cell lung cancer.
    Chen Z; Wang J; Cai L; Zhong B; Luo H; Hao Y; Yu W; Wang B; Su C; Lei Y; Bella AE; Xiang AP; Wang T
    PLoS One; 2014; 9(2):e85584. PubMed ID: 24498263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nestin regulates proliferation, migration, invasion and stemness of lung adenocarcinoma.
    Narita K; Matsuda Y; Seike M; Naito Z; Gemma A; Ishiwata T
    Int J Oncol; 2014 Apr; 44(4):1118-30. PubMed ID: 24481417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer.
    Cao J; Song Y; Bi N; Shen J; Liu W; Fan J; Sun G; Tong T; He J; Shi Y; Zhang X; Lu N; He Y; Zhang H; Ma K; Luo X; Lv L; Deng H; Cheng J; Zhu J; Wang L; Zhan Q
    Cancer Res; 2013 Jun; 73(11):3326-35. PubMed ID: 23592755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1.
    Romero OA; Torres-Diz M; Pros E; Savola S; Gomez A; Moran S; Saez C; Iwakawa R; Villanueva A; Montuenga LM; Kohno T; Yokota J; Sanchez-Cespedes M
    Cancer Discov; 2014 Mar; 4(3):292-303. PubMed ID: 24362264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
    Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
    Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.
    Banks-Schlegel SP; Gazdar AF; Harris CC
    Cancer Res; 1985 Mar; 45(3):1187-97. PubMed ID: 2578876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas.
    Ishiwata T; Teduka K; Yamamoto T; Kawahara K; Matsuda Y; Naito Z
    Oncol Rep; 2011 Jul; 26(1):91-9. PubMed ID: 21503585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
    Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R
    Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.